Infertility in polycystic ovary syndrome - Focus on low-dose gonadotropin treatment

被引:70
作者
Gorry, Anwen
White, Davinia M.
Franks, Stephen [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London W12 0NN, England
[2] St Marys Hosp, Reprod Med Unit, London W2 1PG, England
关键词
anovulation; luteinizing hormone; follicle-stimulating hormone; insulin; obesity;
D O I
10.1385/ENDO:30:1:27
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Polycystic ovary syndrome accounts for more than 75% of cases of anovulatory infertility. The mechanism of anovulation is uncertain but there is evidence that arrested antral follicle development is associated with the abnormal endocrine profile, in particular the interaction of insulin and LH on granulosa cell differentiation. In terms of management, induction of ovulation can be achieved in most cases by the use of antiestrogens. Treatment of clomiphene-resistant subjects is difficult; conventional doses of gonadotropins are associated with high rates of ovarian hyperstimulation syndrome and multiple pregnancy. On the other hand, low-dose gonadotropin therapy has proven effective in inducing unifollicular ovulation and, in this review, we present, in detail, a recent analysis the results from this center. The cumulative conception rate after six cycles was more than 50% and, importantly, the multiple pregnancy rate was only 3%. Weight reduction in obese subjects with PCOS not only increases the chance of fertility but may also improve the long-term prognosis with regard to development of diabetes. lnsulin-sensitizing drugs such as metformin may also have a place in treatment of PCOS.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 46 条
[1]
[Anonymous], COCHRANE DATABASE SY
[2]
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].
Azziz, R ;
Ehrmann, D ;
Legro, RS ;
Whitcomb, RW ;
Hanley, R ;
Fereshetian, AG ;
O'Keefe, M ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632
[3]
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome:: prospective, randomized comparison between low-dose step-up and modified step-down regimens [J].
Balasch, J ;
Fábregues, F ;
Creus, M ;
Puerto, B ;
Peñarrubia, J ;
Vanrell, JA .
HUMAN REPRODUCTION, 2001, 16 (04) :652-656
[4]
CUMULATIVE CONCEPTION AND LIVE BIRTH-RATES AFTER THE TREATMENT OF ANOVULATORY INFERTILITY - SAFETY AND EFFICACY OF OVULATION INDUCTION IN 200 PATIENTS [J].
BALEN, AH ;
BRAAT, DDM ;
WEST, C ;
PATEL, A ;
JACOBS, HS .
HUMAN REPRODUCTION, 1994, 9 (08) :1563-1570
[5]
Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial [J].
Bayram, N ;
van Wely, M ;
Kaaijk, EM ;
Bossuyt, PMM ;
van der Veen, F .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7433) :192-195
[6]
BROWN J B, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P289
[8]
ChavezRoss A, 1997, J MATH BIOL, V36, P95
[9]
WEIGHT-LOSS RESULTS IN SIGNIFICANT IMPROVEMENT IN PREGNANCY AND OVULATION RATES IN ANOVULATORY OBESE WOMEN [J].
CLARK, AM ;
LEDGER, W ;
GALLETLY, C ;
TOMLINSON, L ;
BLANEY, F ;
WANG, X ;
NORMAN, RJ .
HUMAN REPRODUCTION, 1995, 10 (10) :2705-2712
[10]
HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME - CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS [J].
CONWAY, GS ;
HONOUR, JW ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1989, 30 (04) :459-470